Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer
Authors
Keywords
-
Journal
Future Oncology
Volume 11, Issue 12, Pages 1775-1789
Publisher
Future Medicine Ltd
Online
2015-06-15
DOI
10.2217/fon.15.80
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2015) Peter A. Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models
- (2014) Ute Hoch et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer
- (2013) John P. Crown et al. JOURNAL OF CLINICAL ONCOLOGY
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
- (2013) Ahmad Awada et al. LANCET ONCOLOGY
- A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
- (2012) G. S. Jameson et al. CLINICAL CANCER RESEARCH
- A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer
- (2011) A. G. Pallis et al. ANNALS OF ONCOLOGY
- Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives
- (2011) Nagi S. El Saghir et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
- (2010) Carlos H. Barrios et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
- (2010) O. Pagani et al. JNCI-Journal of the National Cancer Institute
- Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer
- (2009) Hee Yeon Seo et al. INVESTIGATIONAL NEW DRUGS
- Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
- (2009) Alvaro Moreno-Aspitia et al. MAYO CLINIC PROCEEDINGS
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search